Q1 2025 KP Tissue Inc Earnings Call Transcript
Key Points
- KP Tissue Inc (KPTSF) reported a strong adjusted EBITDA of $75.8 million for Q1 2025, reflecting a nearly 13% year-over-year growth.
- Revenue increased by 13.9% year-over-year to $546.1 million, driven by higher sales volume and favorable selling prices.
- The newly deployed LDC paper machine in Sherbrooke exceeded startup expectations and is expected to meet all in-house paper requirements by Q2 2025.
- The company maintained a stable market share in the bathroom tissue and paper towel categories, with improvements in facial tissue market share.
- KP Tissue Inc (KPTSF) achieved a 26% reduction in GHG emissions and a 35% decrease in water consumption as part of its sustainability efforts.
- Profitability in the away from home segment decreased year-over-year due to external purchase paper and higher fiber prices.
- Higher pulp prices and greater freight costs negatively impacted the company's profitability.
- The company faces potential risks from tariffs and trade disruptions, which could affect financial performance.
- CapEx increased by $15 million due to carryover on the Sherbrooke expansion project, impacting cash flow.
- The economic uncertainty and volatility delayed the announcement of potential new growth projects, such as the 3T expansion.
Good morning and welcome to KP Tissue first quarter 2025 results conference call.(Operator Instructions)
I will now turn the call over to Doris Grbic, Director of investor relations.
You may begin your conference.
Thank you, operator. Good morning, everyone, and thank you for joining us to review Krueger Products first quarter 2025 financial results. With me this morning is Dino Bianco, the CEO of KP Tissue and Kruger Products, and Michael Keays, the CFO of KP Tissue and Kruger Products. Today's discussion will include certain forward-looking statements, actual results that differ materially from these forward-looking statements due to known and unknown risks and uncertainties.
A list of risk factors can be found in our public filing.
In addition, today's discussion will include certain non-gap financial measures. The reconciliation of these non-gap financial measures to the most comparable GAAP measure can be found in our MDNA.
The press release reporting our Q1
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
